UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000006007
Receipt number R000007062
Scientific Title Comparison of efficacy between fixed combination of latanoprost/timolol + dorzolamide and fixed combination of dorzolamide/timolol + latanoprost in glaucoma patients with a histry of treatment with three unfixed eyedrops.
Date of disclosure of the study information 2011/07/21
Last modified on 2013/06/24 16:43:33

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Comparison of efficacy between fixed combination of latanoprost/timolol + dorzolamide and fixed combination of dorzolamide/timolol + latanoprost in glaucoma patients with a histry of treatment with three unfixed eyedrops.

Acronym

Comparison of efficacy between two different fixed combination eyedrops.

Scientific Title

Comparison of efficacy between fixed combination of latanoprost/timolol + dorzolamide and fixed combination of dorzolamide/timolol + latanoprost in glaucoma patients with a histry of treatment with three unfixed eyedrops.

Scientific Title:Acronym

Comparison of efficacy between two different fixed combination eyedrops.

Region

Japan


Condition

Condition

glaucoma

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To compare intraocular pressure-lowering efficacy between fixed combination of latanoprost/timolol + dorzolamide and fixed combination of dorzolamide/timolol + latanoprost.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

intraocular pressure

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Eye drops of fixed combination of latanoprost/timolol + dorzolamide.
Tree-month observation.

Interventions/Control_2

Eye drops of fixed combination of dorzolamide/timolol + latanoprost.
Tree-month observation.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients with primary open-angle glaucoma whose intraocular pressures are controlled by unfixed combination of latanoprost, timolol, and dorzolamide/brinzolamide.

Key exclusion criteria

1) Patients with contraindication or careful administration in adopted eye drops.
2) MD value <-15 dB in Humphrey visual field analyzer.
3) Best corrected visual acuity <0.5.
4) Spherical equivalent <-9D or >9D.
5) Difference of spherical equivalent between right and left eye >3D
6) Patients with corneal abnormality that hinders intraocular pressure-measurement.
7) Insufficient mydriasis that inhibit observation of optic nerve disc.
8) Histry of ocular surgery and/or laser treatment except cataract surgery.
9) Retinal disease that affect visual field.
10) Patients who are considerd as appropriate by doctors in charge.

Target sample size

40


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hidenobu Tanihara

Organization

Kumamoto University

Division name

Department of Ophthalmology and Visual Science

Zip code


Address

1-1-1 Honjo, Kumamoto

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name

Organization

Kumamoto University

Division name

Department of Ophthalmology and Visual Science

Zip code


Address


TEL

096-373-5247

Homepage URL


Email



Sponsor or person

Institute

Kumamoto University

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology

Organization

Division

Category of Funding Organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2011 Year 07 Month 21 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2011 Year 07 Month 11 Day

Date of IRB


Anticipated trial start date

2011 Year 07 Month 01 Day

Last follow-up date

2013 Year 06 Month 24 Day

Date of closure to data entry

2013 Year 06 Month 24 Day

Date trial data considered complete

2013 Year 06 Month 24 Day

Date analysis concluded

2013 Year 06 Month 24 Day


Other

Other related information



Management information

Registered date

2011 Year 07 Month 20 Day

Last modified on

2013 Year 06 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000007062


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name